Vaccinia virus GLV-1h153 in combination with 131I shows increased efficiency in treating triple-negative breast cancer

Vaccinia Virus GLV-1h153 Is Effective in Treating and Preventing Metastatic Triple-Negative Breast Cancer

(2012) Sepideh Gholami et al.   ANNALS OF SURGERY

SPECT/CT Imaging of hNIS -Expression after Intravenous Delivery of an Oncolytic Adenovirus and 131I

(2012) Maria Rajecki et al.   PLoS One

Insertion of the human sodium iodide symporter to facilitate deep tissue imaging does not alter oncolytic or replication capability of a novel vaccinia virus

(2011) Dana Haddad et al.   Journal of Translational Medicine

Feasibility of Adenovirus-Mediated hNIS Gene Transfer and 131I Radioiodine Therapy as a Definitive Treatment for Localized Prostate Cancer

(2011) Kenneth N Barton et al.   MOLECULAR THERAPY

Novel therapy for anaplastic thyroid carcinoma cells using an oncolytic vaccinia virus carrying the human sodium iodide symporter

(2011) Sepideh Gholami et al.   SURGERY

Endogenous NIS Expression in Triple-Negative Breast Cancers

(2009) Corinne Renier et al.   ANNALS OF SURGICAL ONCOLOGY

Regression of human pancreatic tumor xenografts in mice after a single systemic injection of recombinant vaccinia virus GLV-1h68

(2009) Y. A. Yu et al.   MOLECULAR CANCER THERAPEUTICS

Use of an oncolytic vaccinia virus for the treatment of canine breast cancer in nude mice: preclinical development of a therapeutic agent

(2008) I Gentschev et al.   CANCER GENE THERAPY

Novel Oncolytic Agent GLV-1h68 Is Effective Against Malignant Pleural Mesothelioma

(2008) Kaitlyn J. Kelly et al.   HUMAN GENE THERAPY

Real-time intraoperative detection of melanoma lymph node metastases using recombinant vaccinia virus GLV-1h68 in an immunocompetent animal model

(2008) Kaitlyn J. Kelly et al.   INTERNATIONAL JOURNAL OF CANCER

Oncolytic Vaccinia Virotherapy of Anaplastic Thyroid Cancerin Vivo

(2008) Shu-Fu Lin et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM